How would you approach a premenopausal woman with HR+, HER2- metastatic breast and a PIK3CA mutation?

1 Answers

Mednet Member

Medical Oncology · Baptist Health South Florida

Ovarian ablation of some sort + AI + CDK 4/6 inhibitor. At relapse, consider fulvestrant + alpelisib.